SARS-CoV-2快速即时抗原诊断的准确性:更新系统综述与Meta分析及影响因素Meta回归分析
该更新系统综述与Meta分析纳入194项研究、221,878次抗原快速诊断检测,以RT-PCR为参考,汇总抗原快速诊断检测敏感性72.0%、特异性98.9%;遵循厂家说明时敏感性升至76.3%;Ct值越低、症状出现第一周内及有症状者敏感性更高,Ct值是影响敏感性的最主要因素。
要点
- 抗原快速诊断检测汇总敏感性72.0%(95%CI 69.8至74.2),特异性98.9%(95%CI 98.6至99.1)。
- 遵循厂家说明时敏感性76.3%(95%CI 73.7至78.7)。
- Ct值<20和<25时敏感性分别为97.9%和90.6%,高病毒载量时抗原快速诊断检测可检出几乎所有(>90%)感染者。
核心结论
- 抗原快速诊断检测可检出大多数SARS-CoV-2感染者,高病毒载量时几乎全部(>90%)可检出;Ct值估计的病毒载量是其敏感性最主要影响因素,尤其适用于检出高病毒载量、最可能传播病毒者。
研究设计与样本
- 更新系统综述与Meta分析,2021年8月31日前系统检索预印本与同行评议数据库,纳入194项研究、221,878次抗原快速诊断检测,以RT-PCR为参考;研究注册号PROSPERO CRD42020225140。
主要发现
- 汇总抗原快速诊断检测敏感性72.0%(95%CI 69.8至74.2),特异性98.9%(95%CI 98.6至99.1)。
- 遵循厂家说明时敏感性76.3%(95%CI 73.7至78.7)。
- Ct值<20和<25时敏感性分别为97.9%(95%CI 96.9至98.9)和90.6%(95%CI 88.3至93.0),Ct值≥25和≥30时分别为54.4%(95%CI 47.3至61.5)和18.7%(95%CI 13.9至23.4)。
- 调整检测流程与患者症状状态后,平均Ct值每降低1个单位,敏感性估计增加2.9个百分点(95%CI 1.7至4.0);真阳性平均Ct值22.2(95%CI 21.5至22.8)低于假阴性30.4(95%CI 29.7至31.1)。
- 症状出现第一周内检测敏感性81.9%(95%CI 77.7至85.5),高于1周后51.8%(95%CI 41.5至61.9);有症状者76.2%(95%CI 73.3至78.9)高于无症状者56.8%(95%CI 50.9至62.4),但两者效应主要由样本Ct值驱动;鼻咽及鼻咽/口咽合并样本敏感性70.8%(95%CI 68.3至73.2),前鼻/中鼻甲样本77.3%(95%CI 73.0至81.0)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 纳入研究在病毒载量评估和样本来源方面存在异质性。
- 为进一步量化其他影响检测敏感性因素的效果,需要临床准确性研究的标准化以及获取患者层面的Ct值和症状持续时间。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Comprehensive information about the accuracy of antigen rapid diagnostic tests (Ag-RDTs) for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is essential to guide public health decision makers in choosing the best tests and testing policies. In August 2021, we published a systematic review and meta-analysis about the accuracy of Ag-RDTs. We now update this work and analyze the factors influencing test sensitivity in further detail. METHODS AND FINDINGS: We registered the review on PROSPERO (registration number: CRD42020225140). We systematically searched preprint and peer-reviewed databases for publications evaluating the accuracy of Ag-RDTs for SARS-CoV-2 until August 31, 2021. Descriptive analyses of all studies were performed, and when more than 4 studies were available, a random-effects meta-analysis was used to estimate pooled sensitivity and specificity with reverse transcription polymerase chain reaction (RT-PCR) testing as a reference. To evaluate factors influencing test sensitivity, we performed 3 different analyses using multivariable mixed-effects meta-regression models. We included 194 studies with 221,878 Ag-RDTs performed. Overall, the pooled estimates of Ag-RDT sensitivity and specificity were 72.0% (95% confidence interval [CI] 69.8 to 74.2) and 98.9% (95% CI 98.6 to 99.1). When manufacturer instructions were followed, sensitivity increased to 76.3% (95% CI 73.7 to 78.7). Sensitivity was markedly better on samples with lower RT-PCR cycle threshold (Ct) values (97.9% [95% CI 96.9 to 98.9] and 90.6% [95% CI 88.3 to 93.0] for Ct-values <20 and <25, compared to 54.4% [95% CI 47.3 to 61.5] and 18.7% [95% CI 13.9 to 23.4] for Ct-values ≥25 and ≥30) and was estimated to increase by 2.9 percentage points (95% CI 1.7 to 4.0) for every unit decrease in mean Ct-value when adjusting for testing procedure and patients' symptom status. Concordantly, we found the mean Ct-value to be lower for true positive (22.2 [95% CI 21.5 to 22.8]) compared to false negative (30.4 [95% CI 29.7 to 31.1]) results. Testing in the first week from symptom onset resulted in substantially higher sensitivity (81.9% [95% CI 77.7 to 85.5]) compared to testing after 1 week (51.8%, 95% CI 41.5 to 61.9). Similarly, sensitivity was higher in symptomatic (76.2% [95% CI 73.3 to 78.9]) compared to asymptomatic (56.8% [95% CI 50.9 to 62.4]) persons. However, both effects were mainly driven by the Ct-value of the sample. With regards to sample type, highest sensitivity was found for nasopharyngeal (NP) and combined NP/oropharyngeal samples (70.8% [95% CI 68.3 to 73.2]), as well as in anterior nasal/mid-turbinate samples (77.3% [95% CI 73.0 to 81.0]). Our analysis was limited by the included studies' heterogeneity in viral load assessment and sample origination. CONCLUSIONS: Ag-RDTs detect most of the individuals infected with SARS-CoV-2, and almost all (>90%) when high viral loads are present. With viral load, as estimated by Ct-value, being the most influential factor on their sensitivity, they are especially useful to detect persons with high viral load who are most likely to transmit the virus. To further quantify the effects of other factors influencing test sensitivity, standardization of clinical accuracy studies and access to patient level Ct-values and duration of symptoms are needed.
引用
- Brümmer LE, Katzenschlager S, McGrath S, et al. Accuracy of rapid point-of-care antigen-based diagnostics for SARS-CoV-2: An updated systematic review and meta-analysis with meta-regression analyzing influencing factors. PLoS Med. 2022. PMID: 35617375. doi:10.1371/journal.pmed.1004011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。